Abstract
Sample: N=100 Ob/Gyns currently practicing in the United States
Countries Covered: United States
Applicability: The information presented in this report has direct applicability to sales, marketing, professional education, advertising, public relations, forecasting, market research and other business functions.
Why purchase this report?
Determine the potential for pharmaceutical treatments in the Obstetrics and Gynecology market, including AUB hormone therapy and birth control therapy / contraceptives, by gaining knowledge of treatment share (i.e. the percentage of birth control patients electing a birth control medical device, the percent electing an oral contraceptive, the percent electing non-oral birth control, etc.)
Acquire new customers by improving sales rep and professional education messages to Obstetricians and Gynecologists
Retain customers by learning how sales reps can connect with Ob/Gyns to increase customer satisfaction and loyalty
Mitigate competitive threats by determining how your company' s reps compare to your competitors
Improve your professional education events by determining how your company' s events compare to your competitors
Increase attendance of your professional education events by incorporating Ob/Gyns doctors' feedback on incentives and quality of your events, relative to the 17 featured pharmaceutical companies.
Capitalize on unoccupied positions and unmet needs with our Opportunity Index, which illustrates the relative competitive positioning of 17 leading pharmaceutical companies based on their performance in 10 critical business areas (prioritized by importance).
Communicate on your company' s strengths to Ob/Gyn doctors and improve in areas of relative weakness.
Understand Ob/Gyn doctors' awareness, experience and use of 79 featured pharmaceutical brands from 4 therapeutic categories (AUB hormone therapy, oral birth control / oral contraceptives, non-oral birth control / contraceptives and birth control devices.)
Evaluate market share as well as Ob/Gyn practitioners' levels of satisfaction and loyalty for each of the 79 featured pharmaceutical brands.
Read voice-of-the-customers feedback directly from Ob/Gyns (in their own words) that provide you with simple, actionable steps to: acquire new customers, prevent current customers from discontinuing use of your products, increase customers' loyalty to your products and increase satisfaction with your products.
Exploit your competitors' weaknesses by learning why some Ob/Gyns are dissatisfied with competitors' products, and turn these prospects into loyal, satisfied customers by meeting their unmet needs.
Table of Contents
Introduction & Report Overview
- Measurement Objectives
- Sample Design & Distribution / Measurement & Data Collection Design
- How to read this report
Executive Summary & Key Findings
Detailed Findings
Section 1: Ob/Gyn Practices, Patients & Treatments
- 1.1 Ob/Gyn Demographics
- a. Number of years Ob/Gyns have been in practice
- b. % of total working hours Ob/Gyns spend at the office (vs. hospital)
- c. Obstetrician & Gynecologist gender
- 1.2 Procedures & Trends
- a. # of featured types of surgical procedures performed per month (i.e. myomectomy, tubal ligation, global endometrial ablation, etc.)
- b. % of feature surgical procedures performed at various sites of care (hospital, surgery center, office, etc.)
- c. Surgical procedural trends (expected trend for each featured surgical procedure)
- 1.3 The AUB Patient Profile
- a. # of patients seen in a typical month
- b. % of patients seen for AUB/DUB
- c. % of AUB patients seen for various conditions
- d. % of AUB patients that receive various treatments
- e. AUB Treatment Flow Chart
- f. Trend in patients electing surgical procedures for AUB
- g. % of AUB patients previously treated by another Ob/Gyn
- h. AUB patients age
- i. AUB patients ethnicity
- 1.4 Birth Control Patients & Treatments
- a. % of total patients seen for birth control
- b. % of patients that receive various types of birth control treatments
- c. Birth Control Treatment Flow Chart
- d. % of birth control patients that request a specific type of birth control
Section 2: Increasing the Effectiveness of Sales & Marketing
- 2.1 Pharmaceutical Sales Representatives
- a. What type of sales rep contact do Ob/Gyns consider to be an actual visit?
- b. How many total sales rep visits to Ob/Gyns receive per month?
- c. Frequency of sales rep visits for each featured pharmaceutical company
- d. Quality of information presented during featured companies' sales rep visits
- e. Sales Force - relative performance positioning chart (for featured companies)
- f. How often do Ob/Gyns prefer to receive sales rep visits?
- 2.2 Professional Medical Education
- a. How many company-sponsored Prof Ed events do Ob/Gyns attend per year?
- b. Frequency of professional education attendance for each featured company
- c. Perceived quality of each companies' professional education events
- d. Professional education - derived z-scores (for each featured company)
- e. Prof Ed - relative performance positioning chart (for featured companies)
- 2.3 Marketing and Information Sources
- a. How to Ob/Gyns prefer to learn about new products?
- b. How to Ob/Gyns prefer to learn about new methods, techniques, treatments?
- c. How to Ob/Gyns market their practices?
- d. Number of hours Ob/Gyns spend on internet & reading medical journals for professional purposes
- 2.3 Ob/Gyn Attitudes
- a. Ob/Gyns' attitudes on various product statements
Section 3: The Opportunity Index
- 3.1 Importance
- a. Relative importance of considerations that drive product selection
- b. Relative importance of considerations (90% confidence intervals)
- 3.2 Experience & Associations
- a. Awareness and experience with featured pharmaceutical companies
- b. Top of mind products associated with featured manufacturers
- c. Top of mind manufacturer associated with featured considerations
- 3.3 Performance
- a. Performance ratings on various considerations (each featured company is measured)
- b. Performance ratings - standardized by column/consideration
- c. Performance ratings standardized by row/manufacturer
- d. Importance/Performance Gap Analysis (for each featured company)
- e. Relative Competitive Positioning Quadrant Chart (includes all featured companies)
Section 4: Brand Usage, Satisfaction & Loyalty
- 4.1 Product Use, Satisfaction & Loyalty
- c. AUB Hormone therapy
- i. Experience (unaware, aware but never used, currently use, used in past and discontinued
- ii. Use, Satisfaction & Loyalty
- iii. Share
- iv. Quadrant Chart - Relative Competitive Positioning on Satisfaction & Loyalty
- d. Oral Birth Control
- i. Experience
- ii. Use, Satisfaction & Loyalty
- iii. Share
- iv. Quadrant Chart - Relative Competitive Positioning on Satisfaction & Loyalty
- e. Non-Oral Birth Control
- i. Experience
- ii. Use, Satisfaction & Loyalty
- iii. Share
- iv. Relative Positioning on Satisfaction & Loyalty
- f. Birth Control Devices
- i. Experience
- ii. Use, Satisfaction & Loyalty
- iii. Share
- iv. Quadrant Chart - Relative Competitive Positioning on Satisfaction & Loyalty
- c. AUB Hormone therapy
